224 related articles for article (PubMed ID: 36029014)
21. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.
Zheng G; Chen J; Li H; Glickson JD
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17757-62. PubMed ID: 16306263
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
23. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
24. Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy.
Jiang X; Han W; Liu J; Mao J; Lee MJ; Rodriguez M; Li Y; Luo T; Xu Z; Yang K; Bissonnette M; Weichselbaum RR; Lin W
Adv Sci (Weinh); 2022 Aug; 9(24):e2201614. PubMed ID: 35748191
[TBL] [Abstract][Full Text] [Related]
25. Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency.
Li W; Fu J; Ding Y; Liu D; Jia N; Chen D; Hu H
Acta Biomater; 2019 Sep; 96():456-467. PubMed ID: 31260821
[TBL] [Abstract][Full Text] [Related]
26. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
Layek B; Sadhukha T; Panyam J; Prabha S
Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
28. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
29. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies.
Sana S; Reddy VG; Srinivasa Reddy T; Tokala R; Kumar R; Bhargava SK; Shankaraiah N
Bioorg Chem; 2021 May; 110():104765. PubMed ID: 33677248
[TBL] [Abstract][Full Text] [Related]
30. Low density lipoprotein receptor (LDLR)-targeted lipid nanoparticles for the delivery of sorafenib and Dihydroartemisinin in liver cancers.
Wang Z; Duan X; Lv Y; Zhao Y
Life Sci; 2019 Dec; 239():117013. PubMed ID: 31678287
[TBL] [Abstract][Full Text] [Related]
31. Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.
Lestavel-Delattre S; Martin-Nizard F; Clavey V; Testard P; Favre G; Doualin G; Houssaini HS; Bard JM; Duriez P; Delbart C
Cancer Res; 1992 Jul; 52(13):3629-35. PubMed ID: 1617635
[TBL] [Abstract][Full Text] [Related]
32. Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities.
Yang F; Yu LZ; Diao PC; Jian XE; Zhou MF; Jiang CS; You WW; Ma WF; Zhao PL
Bioorg Chem; 2019 Nov; 92():103260. PubMed ID: 31525523
[TBL] [Abstract][Full Text] [Related]
33. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity.
Ashraf SM; Mahanty S; Rathinasamy K
Life Sci; 2021 Dec; 287():120105. PubMed ID: 34756929
[TBL] [Abstract][Full Text] [Related]
34. Implications of nanoscale based drug delivery systems in delivery and targeting tubulin binding agent, noscapine in cancer cells.
Chandra R; Madan J; Singh P; Chandra A; Kumar P; Tomar V; Dass SK
Curr Drug Metab; 2012 Dec; 13(10):1476-83. PubMed ID: 22571485
[TBL] [Abstract][Full Text] [Related]
35. Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers.
Yaghmur A; Østergaard J; Mu H
Adv Drug Deliv Rev; 2023 Dec; 203():115136. PubMed ID: 37944644
[TBL] [Abstract][Full Text] [Related]
36. Tubulin-Based Nanotubes as Delivery Platform for Microtubule-Targeting Agents.
Kim J; Lee J; Lee J; Keum H; Kim Y; Kim Y; Yu B; Lee SY; Tanaka J; Jon S; Choi MC
Adv Mater; 2020 Aug; 32(33):e2002902. PubMed ID: 32579276
[TBL] [Abstract][Full Text] [Related]
37. Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery.
Pang J; Zhao L; Zhang L; Li Z; Luan Y
J Colloid Interface Sci; 2013 Apr; 395():31-9. PubMed ID: 23312579
[TBL] [Abstract][Full Text] [Related]
38. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
39. Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.
Reynolds L; Mulik RS; Wen X; Dilip A; Corbin IR
Nanomedicine (Lond); 2014 Jul; 9(14):2123-41. PubMed ID: 24397600
[TBL] [Abstract][Full Text] [Related]
40. ZnO Nanoparticles Catalyst in the Synthesis of Bioactive Fused Pyrimidines as Anti-breast Cancer Agents Targeting VEGFR-2.
Dawood DH; Abbas EMH; Farghaly TA; Ali MM; Ibrahim MF
Med Chem; 2019; 15(3):277-286. PubMed ID: 30207239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
